Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy

Heart

Volumn 77, Issue 6, 1997, Pages 583-584

  James, P R ^a   Hardman, S M C ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ENALAPRIL; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; WARFARIN;

ADULT; CASE REPORT; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HEPATITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030847124     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.6.583     Document Type: Short Survey

References (5)

1. Lupon-Roses J, Simo-Canonge R, Lu-Cortez L, Permanyer-Miralda G, Allende-Mondus H. Probable early acute hepatitis with parentral amiodarone. Clin Cardiol 1986;9:225-9.
2. Pye M, Northcote RJ, Cobbe SM. Acute hepatitis after parenteral amiodarone administration. Br Heart J 1988;59: 690-1.
3. Stephenson RNS, Nayam TH, Davies JR. Acute hepatic dysfunction following parenteral amiodarone administration. Postgrad Med J 1989,65:707-8.
4. Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle? Gut 1993;34:565-6.
5. Ruter HD. The E-ferol syndrome solved? In: Dukes MNG, Beeley L, eds. Side effects of drugs, annual 12: a worldwide survey of new data and trends. Amsterdam: Elsevier, 1988:329.